SECURITY VAULT ARRIVES AT VODIS PHARMACEUTICALS FACILITY
(firmenpresse) - SECURITY VAULT ARRIVES AT VODIS PHARMACEUTICALS FACILITY
December 23, 2014 - Vancouver, British Columbia - Vodis Pharmaceuticals Inc. (the Company or Vodis) (CSE: VP / FSE: 1JV) is pleased to announce the arrival of a brand new Tier 8 upgraded vault to further ensure Health Canada's approval at the time of inspection. The vault will be the final component to be installed and the company has provided Health Canada notice of its readiness for a final inspection.
Otto Folprecht, CEO & Director states: I am excited that the Company has finally received the Vault, as this is the last item to be installed prior to final inspection. Over the next several days the Company and its contractors will install the safe. We have notified Health Canada that we are ready for a final inspection, and are waiting for a date from the Government of Canada. We have spent the past year preparing our systems and building out our 12,000 square facility in order to pass Health Canadas world-leading, rigorous requirements.
Since Vodis received its Ready-To-Build Permit in January of 2014, the company has worked diligently to upgrade its production facility to Health Canada's standards
ABOUT VODIS PHARMACEUTICALS
Vodis is one of Canadas foremost brand names in the medical marijuana business. Its master grow teams have consistently won or placed at each competition they have entered. The company is awaiting a Health Canada inspection to begin production at its state-of-the-art 12,000 square foot facility in Canada, which will have a theoretical capacity of up to 200 pounds per month or up to $8.7 million in annual revenue.
For further information please contact:
Brian Gusko
CFO & Director
Vodis Pharmaceuticals
104-1037 West Broadway
Vancouver, BC V6H 1E3
direct: 1-866-210-1420 ext. 106
web: www.vodis.ca
Forward-Looking Information:
This news release contains forward-looking statement, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. Factors which may prevent these forward looking statements from coming to fruition include whether the Companys announced acquisition will be completed on the terms announced or at all, whether the Company will secure adequate financing to complete the additional work required at its production facility; whether the construction will be completed at the production facility in a timely manner or at all; whether the building can be licensed to grow cannabis; whether we will have success in finding an appropriate i-502 license holder, and negotiating and concluding an agreement with i-502 license holder. Any dollar numbers that have been provided in terms of expectant gross revenue to be generated and profit is subject to the license holder successfully growing and selling the cannabis, and the Company being able to successfully recover the funds from the license holder. All of the forward-looking statements made in this news release are qualified by these cautionary statements and those in our continuous disclosure filings available on SEDAR at www.sedar.com. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Leseranfragen:
Vodis ist eine der renommiertesten Marken in der medizinischen Marihuanabranche Kanadas.
Datum: 23.12.2014 - 14:32 Uhr
Sprache: Deutsch
News-ID 361323
Anzahl Zeichen: 4085
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 399 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SECURITY VAULT ARRIVES AT VODIS PHARMACEUTICALS FACILITY
"
steht unter der journalistisch-redaktionellen Verantwortung von
Vodis Innovative Pharmaceuticals Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
